Melissa Barnett
Obstetrics & Gynecology · Tupelo, MSNPI 1669450425
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,202 of the $49,841 with a category attached, or 92.7%. Organon accounts for 70.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $18,649 and has fallen 70.7% since, to $5,462 in 2025. Among obstetrics & gynecology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $233.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$35K
- Mayne Pharma Commercial LLC$12K
- Merck$1K
- Astellas Pharma US Inc$441
- AbbVie$409
- Exeltis, USA Inc.$198
- plus $627 from 16 others
What the payments were for
- Speaking & faculty fees$46,20293%
- Travel & lodging$3081%
- Food & beverage$3,2326%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 78 | $35,261 |
| Mayne Pharma Commercial LLC | 30 | $11,823 |
| Merck | 4 | $1,082 |
| Astellas Pharma US Inc | 17 | $441 |
| AbbVie | 38 | $409 |
| Exeltis, USA Inc. | 13 | $198 |
| Bayer | 5 | $90 |
| Aspira Women's Health Inc | 1 | $83 |
| Millicent US Inc | 5 | $82 |
| Hologic Sales And Service, LLC | 3 | $65 |
| Daiichi Sankyo Inc. | 4 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Cumberland Pharmaceuticals, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Biogen | 1 | $27 |
| Teleflex LLC | 1 | $18 |
| Pfizer | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Shield Therapeutics Inc | 1 | $13 |
| Lupin Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$30,547
- NEXTSTELLIS$7,930
- ANNOVERA$2,652
How this compares
$49,841 in reported general payments places this provider in the 95th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 84 | $1,698 |
| Acyclovir | 25 | $593 |
| ValacyclovirValacyclovir Hcl | 15 | $452 |
| Escitalopram Oxalate | 18 | $204 |
| Solifenacin Succinate | 11 | $173 |
| Sertraline Hcl | 11 | $111 |
| ProgesteroneProgesterone, Micronized | 14 | $94 |
| Citalopram HbrCitalopram Hydrobromide | 18 | $89 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tupelo
- Joseph McGeheeTupelo$35K
- Elizabeth TarsiTupelo$21K
- David WebbTupelo$10K
- Leody BautistaTupelo$8K
- Laura MarionTupelo$6K
- Brandi McGeheeTupelo$3K
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Ahmet BedestaniFlowood$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.